Purchase Order HHSP284201700250A
- Not listed
- This firm-fixed price purchase order was awarded by the U.S. Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies, testing components, and other products to support biosurveillance and COVID-19 testing efforts. The contract has a ceiling value of $165,918.73 and a completion date of March 12, 2018. It does not utilize any set-aside designations. Qiagen Beverly has received similar prime contracts from HHS...
- The Department of Health and Human Services (HHS) awarded a $331,000.00 Firm Fixed Price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for the provision of lab supplies. This award is not associated with any set-aside designation. Qiagen Beverly, LLC has previously received awards from HHS and the Department of the Air Force Materiel Command to provide products and services in support of the BioWatch program, a nationwide biosurveillance system to detect the...
- This $158,946.49 firm-fixed price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for the provision of laboratory supplies, which are likely to support HHS's biosurveillance and COVID-19 testing efforts, such as the BioWatch program operated by HHS. Qiagen Beverly has received several previous awards from HHS and the Department of the Air Force to supply...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
- This $231,000 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, on April 21, 2022. The contract is for the provision of inventory in support of the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. Qiagen Beverly, LLC, which does business as Qiagen Beverly Inc., is a subsidiary of the parent company Qiagen N.V. No...
- The Department of Health and Human Services (HHS) awarded a Firm Fixed Price purchase order contract to Qiagen Beverly, LLC, a foreign-owned for-profit manufacturer, for $272,250.00 to provide BioWatch inventory. Qiagen Beverly, LLC has previously received other HHS awards to support the BioWatch program, a nationwide biosurveillance system to detect intentional release of biological agents. The contract does not have a set-aside designation. Additional details on the specific products or...
- This federal contract award was made by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for $231,990.00. The contract is for the provision of BioWatch inventory, which supports the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This award did not have a set-aside designation. Qiagen Beverly, LLC is a...
- This federal contract award is for $116,467.47 to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The contract is for "CORONAVIRUS LAB SUPPLIES" and was awarded on February 28, 2020 by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh. The contract is a Firm Fixed Price Purchase Order with a completion date of March 4, 2020. Qiagen is a foreign-owned, for-profit manufacturer that...
- The U.S. Department of Health and Human Services (HHS) awarded a $231,000.00 firm-fixed-price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies in support of the BioWatch program. The BioWatch program is a nationwide biosurveillance system operated by HHS to detect the intentional release of aerosolized biological agents. This award is one of several contracts Qiagen Beverly, LLC has received from HHS to support the BioWatch...
- This is a $148,157.70 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for other unspecified functions and does not have a set-aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under...
This is a $165,197.49 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer. The contract is for the provision of lab supplies, with no set-aside designation. Past awards to Qiagen Beverly, LLC have primarily supported the HHS BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This includes purchase orders for BioWatch inventory, lab supplies, and testing components. The vendor has also received a $596,229 definitive contract from the Department of the Air Force Materiel Command to provide COVID-19 testing components to expand HHS testing capacity. No further details on the specific lab supplies being provided under this contract are available in the information provided.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 3 | Change Order | $1.9k | 9/17/18 | |
| 2 | Change Order | $211 | 5/18/18 | |
| 1 | Supplemental Agreement for work within scope | $612 | 1/24/18 | |
| Not listed | Not listed | $162.5k | 8/3/17 |